Prof. Nebojsa Lalic
Faculty of Medicine University of Belgrade, Clinic for Endocrinology, Diabetes and Metabolic Diseases, Belgrade, Serbia
Nebojša M. Lalić (1958), MD, PhD, FRCP, is currently Professor of Internal Medicine at the Faculty of Medicine, University of Belgrade as well as Director and Head of the Department for Metabolic Disorders, Intensive Treatment and Cell Therapy in Diabetes, Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia in Belgrade. Professor Lalic graduated in 1982 at Faculty of Medicine in Belgrade where he completed residency in Internal medicine in 1990, as well as his PhD thesis in 1993. In 1991, he was a visiting scientist at the Clinical Research Section and Immunology Section, Joslin Diabetes Center, Boston, USA. The principal interest of Professor Lalic scientific work in diabetology/endocrinology has been concentrated on the relationship between insulin secretion and insulin sensitivity impairments in Type 2 diabetes, their relevance for the pathogenesis of diabetes and its late complications and the possibilities of their therapeutic modulation (especially insulin pump treatment). In this context, he is also intensively involved in the metabolic studies of the possibilities of early detection and prevention of Type 2 diabetes, as well as of the late diabetic complications and comorbidities, especially coronary heart disease, ischemic stroke and neurodegenerative disorders. Professor Lalic has been involved in more than 200 papers in extenso in international journals, chapters, monographies and textbooks. He has been an investigator in several national and international projects, reviewer at many international meetings or journals.
Professor Lalic has been Chair of the national expert committee for diabetes from 2002. Moreover, he is member in several national and international medical associations and societies. Until now he chaired organizing committee of three EASD Postgraduate Courses in Belgrade. Also, he is at present member of the Board of the IDF Europe.